Skip to content
Disclosery

EXANE DERIVATIVES: MBUU position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MBUU, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 7 MBUU shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 7 shares
    Change vs previous 13F -1,816 shares

    <0.01% of the 13F portfolio, value $369.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,823 shares
    Change vs previous 13F -370 shares

    0.03% of the 13F portfolio, value $105,746.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,193 shares
    Change vs previous 13F -659 shares

    0.04% of the 13F portfolio, value $150,719.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,852 shares
    Change vs previous 13F -470 shares

    0.05% of the 13F portfolio, value $199,576.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,322 shares
    Change vs previous 13F -1,116 shares

    0.06% of the 13F portfolio, value $249,078.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4,438 shares
    Change vs previous 13F -1,826 shares

    0.11% of the 13F portfolio, value $353,604.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 6,264 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $391,106.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).